Search

everythinglearnresearchcommunity

for

Search:↓

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Higher levels of the DP2 receptor may lead to hair loss.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Blocking Prostaglandin D₂ may help treat hair loss.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

People with Alopecia areata have higher levels of prostaglandin D2 in their blood and tissues.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Latanoprost eye drops may cause skin depigmentation.

Ageratum Conyzoides, when taken orally, can effectively reduce hair loss and improve hair growth.

Overexpression of COX-2 in mice skin causes abnormal skin and hair development.

Minoxidil boosts hair growth by activating PGHS-1.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Overexpression of COX-2 causes early hair loss in mice, but can be prevented with a COX-2 inhibitor.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

A protein called HMGB1 helps hair grow by affecting prostaglandin metabolism.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.